This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Facioscapulohumeral Muscular Dystrophy
and you are
between 18 and 60
years old
The phase for this study is not defined.
Show me locations

The purpose

On the basis of published data and the investigators' results indicating that oxidative stress may contribute to the peripheral skeletal muscle dysfunction in patients with FSHD, the investigators propose a study to test whether or not an antioxidant supplementation has a therapeutic interest for patients with FSHD. Their results have important implications for the successful implementation of rational antioxidant therapy in FSHD in which cell loss could be linked to oxidative stress.

Provided treatments

  • Procedure: Taking of blood
  • : needle biopsy of the vastus lateralis muscle
  • : Vit C Vit E Zn Se
  • : Placebo Vit E Placebo Vit C Zn Se

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01596803. The sponsor of the trial is University Hospital, Montpellier and it is looking for 54 volunteers for the current phase.
Official trial title:
Effects of Antioxidants Supplementation on Muscular Function of Patients Affected by Facioscapulohumeral Dystrophy (FSHD)